VNRX Stock Analysis: Buy, Sell, or Hold?
VNRX - VolitionRX Limited Common Stock
$2.26
-0.10 (-4.24%)
▼
5d:
-6.61%
30d:
+1221.64%
90d:
+860.88%
HOLD
LOW Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 21, 2026
6d
Get Alerted When VNRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called VNRX this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: VNRX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: VNRX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$4.04
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$2.51
9.8% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 0.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: VNRX is currently trading at $2.26, which is considered slightly high relative to its 30-day fair value range of $0.05 to $2.30. From a valuation perspective, the stock is trading at a discount (Forward PE: 0.5) compared to its historical average (0.6). Remarkably, the market is currently pricing in an annual earnings decline of 7.2% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, VNRX is in a uptrend. Immediate support is located at $2.01, while resistance sits at $2.78. Short-term momentum is weak, with the stock down 4.2% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $29.21 (+1137.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, VNRX is in a uptrend. Immediate support is located at $2.01, while resistance sits at $2.78. Short-term momentum is weak, with the stock down 4.2% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $29.21 (+1137.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$0.05 -
$2.30
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
60.5%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.2%)
- BULLISH: Trading 1137.6% below Wall St target ($29.21)
- CAUTION: Recommendation downgraded due to -6.6% 5-day decline
Trading Range Analysis
30-Day Trading Range
$0.05 -
$2.30
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$2.01
Resistance Level
$2.78
Current Trend
Uptrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
0.49
Wall Street Target
$29.21
(+1137.6%)
Revenue Growth (YoY)
133.2%
Valuation Discount vs History
-7.2% cheaper
PE vs Historical
0.5 vs 0.6
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-7.2%
(market-implied from PE analysis)
1-Year Target
$2.19
(-7%)
2-Year Target
$2.03
(-14%)
3-Year Target
$1.89
(-20%)
3-Yr Target (if PE normalizes)
(PE: 0→1)
$2.30
(-3%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 0.5 to 0.6
Stabilization Target:
$2.88
(+22.0%)
PE Expansion Potential:
+22.0%
Share & Embed Analysis
Last updated: May 14, 2026 2:43 PM ET
Data refreshes hourly during market hours. Next update: 3:43 PM
Data refreshes hourly during market hours. Next update: 3:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VNRX showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Cameron John Reynolds
BUY
20000 shares
2025-11-17
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 55 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$392 | 62 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$84 | 60 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 62 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 53 HOLD |
